LQDA Liquidia Corporation

$66.74▼ -1.64% Healthcare Other
After hours $67.00▲ +0.39% Sep 11, 7:40 PM ET
Volume 778.5K Avg Volume (10D) 1.03M
Key Metrics & Fundamentals
Market Cap
$5.97B
P/E Ratio
47.7
Div Yield
–%
52W Range
21.15 - 93.61
% vs 50 MA
-12.93%
% vs 200 MA
30.64%
RSI-14
39.8
MACD Histogram
-0.0100
Beta (1Y vs SPY)
0.91
Free Cash Flow
$68.01M
Gross Rev
$171.68M
Gross Profit
$160.13M
EBITDA
$88.39M
COGS
$11.55M
Operating Exp
$74.61M
Operating Income
$85.52M
EBIT
$85.52M
Pretax Income
$81.70M
Net Income
$74.72M
EPS (Diluted)
0.74
Price & Volume History
Loading chart…
Recent News
LQDA Loses 13.9% in a Month: Should Investors Avoid the Stock Now?
Zacks · Sep 11, 2026 6:21 PM
Can a Potential Label Expansion of Yutrepia Boost LQDA's Portfolio?
Zacks · Sep 10, 2026 5:38 PM
Does FDA Fast Track For YUTREPIA In SSc Raynaud’s Change The Bull Case For Liquidia (LQDA)?
Simply Wall St. · Sep 5, 2026 3:08 AM
Is Liquidia (LQDA) Still Undervalued As Fast Track News Tests Its Valuation?
Simply Wall St. · Sep 4, 2026 9:07 PM
Liquidia (LQDA) Stock Looks Stretched On Earnings But Reasonable On Broader Checks
Simply Wall St. · Sep 4, 2026 3:09 PM
Liquidia Corporation’s (LQDA) Yutrepia Launch Continues to Outpace the Expectations
Insider Monkey · Sep 3, 2026 2:10 PM
Sector Update: Healthcare Stocks Edge Higher Pre-Bell Thursday
MT Newswires · Sep 3, 2026 1:21 PM
Liquidia Says US FDA Grants Fast Track Designation to Yutrepia in Systemic Sclerosis
MT Newswires · Sep 3, 2026 12:23 PM
FDA Grants Fast Track Designation to YUTREPIA® for the Treatment of Raynaud's Phenomenon Associated with Systemic Sclerosis
GlobeNewswire · Sep 3, 2026 11:30 AM
Liquidia to Present Posters at the European Respiratory Society (ERS) 2026 Congress
GlobeNewswire · Sep 2, 2026 12:30 PM
Financial Overview - Income Statement Quarterly

See LQDA's money flow as a full page

Social Sentiment
Avg +0.66 · 15 posts
DDNewsEarningsTrade$LQDA DeepDive. $3B marketcap looks incredibly cheap..
r/wallstreetbets · Jan 14, 2026
Strong bullish sentiment due to market cap analysis, competitive positioning, and revenue projections.
positive +0.80
DDNewsDiscussionEarningsPriceTargetLQDA to the moon? Liquidia could blast past $50 if Q2 blows it out of the park
r/wallstreetbets · Aug 6, 2025
The post expresses strong optimism about LQDA, citing technicals, hype, and earnings expectations.
very_positive +0.90
TradeDiscussionHow is this portfolio? Just turned 18 and don't know which stocks to hold.
r/investing · Jul 30, 2025
Comments express concern about LQDA as a speculative, pre-profit stock.
negative +0.10
DDNewsPriceTargetLQDA had a stellar drug launch
r/wallstreetbets · Jul 25, 2025
Strong positive sentiment due to promising sales data and potential market share.
positive +0.80
NewsTradeDiscussionPriceTargetLQDA Bullish Play
r/wallstreetbets · May 20, 2025
The post presents LQDA as a 'bullish play' and highlights positive catalysts like FDA approval and patent expiration.
positive +0.70
Page 1 of 3 (15 total)
AI Analysis

Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.

Not financial advice. All data, scores, charts, and analysis on this site are provided for informational and educational purposes only and do not constitute financial, investment, legal, or tax advice. Past performance is not indicative of future results. See our Legal Notice for full details.
An unhandled error has occurred. Reload 🗙